Market revenue in 2023 | USD 51.5 million |
Market revenue in 2030 | USD 75.5 million |
Growth rate | 5.6% (CAGR from 2023 to 2030) |
Largest segment | Research & manufacturing |
Fastest growing segment | OUTPATIENT FACILITIES |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | OUTPATIENT FACILITIES, RESEARCH & MANUFACTURING, HOSPITALS |
Key market players worldwide | Jeol Ltd, Thermo Fisher Scientific Inc, Bruker Corp, Oxford Instruments PLC, Nanalysis Scientific Corp Ordinary Shares, Absci Corp, QuinStreet Inc, Magritek Ltd, Magnetic Resonance Innovations |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nuclear magnetic resonance spectroscopy market will help companies and investors design strategic landscapes.
Research & manufacturing was the largest segment with a revenue share of 45.44% in 2023. Horizon Databook has segmented the China nuclear magnetic resonance spectroscopy market based on outpatient facilities, research & manufacturing, hospitals covering the revenue growth of each sub-segment from 2018 to 2030.
The NMR spectroscopy market in China is expected to grow at a lucrative rate during the forecast period. This can be attributed to the robust growth of pharmaceutical, biotechnology, and biopharmaceutical sectors in China.
The pharmaceutical industry in China is highly supported by governmental funding. Hence, it has exhibited robust growth in the recent past. Furthermore, China is intensifying research in cancer and hematology. In 2019, the Beijing Xisike Clinical Oncology Research Foundation granted funds to support the expansion of clinical and scientific research in China.
In addition, extensive research activities have been conducted by several pharmaceutical companies in China for developing novel vaccines or therapies for chronic & infectious diseases. Hence, increased R&D initiatives are anticipated to significantly boost the demand for NMR spectroscopy products, supporting market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the China nuclear magnetic resonance spectroscopy market , including forecasts for subscribers. This country databook contains high-level insights into China nuclear magnetic resonance spectroscopy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account